Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Pieris Pharmaceuticals (PIRS).
Pieris Pharmaceuticals, Inc. is implementing a 1-for-80 reverse stock split to boost its stock price above the $1.00 threshold, aiming to meet Nasdaq’s minimum bid price requirement. Set to take effect at market open on April 23, 2024, the move will automatically adjust shareholders’ stock quantities, ensuring no fractional shares remain by rounding up to whole shares. The action doesn’t require shareholder approval and is intended to help the company maintain its Nasdaq listing without changing shareholder equity, except for minimal adjustments due to the rounding of shares.
Learn more about PIRS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue